Preparation and characterization of fusion processed solid dispersions containing a viscous thermally labile polymeric carrier.

The primary aim of the present study was to investigate the ability of hydroxypropyl and methoxyl substituted cellulose ethers to stabilize supersaturated concentrations of itraconazole (ITZ), a poorly water-soluble weak base, after an acid-to-neutral pH transition. A secondary aim of the study was to evaluate the effect of fusion processes on polymer stability and molecular weight. Polymer screening studies showed that stabilization of ITZ supersaturation was related to the molecular weight of the polymer and levels of hydroxypropyl and methoxyl substitution. METHOCEL E50LV (E50LV), which is characterized as having a high melt viscosity, was selected for solid dispersion formulation studies. Hot-melt extrusion processing of E50LV based compositions resulted in high torque loads, low material throughput and polymer degradation. KinetiSol Dispersing, a novel fusion based processing technique, was evaluated as a method to prepare the solid dispersions with reduced levels of polymer degradation. An experimental design revealed that polymer molecular weight was sensitive to shearing forces and high temperatures. However, optimal processing conditions resulted in significantly reduced E50LV degradation relative to HME processing. The technique was effectively utilized to prepare homogenous solid solutions of E50LV and ITZ, characterized as having a single glass transition temperature over a wide range of drug loadings. All prepared compositions provided for a high degree of ITZ supersaturation stabilization.

[1]  Bruno C. Hancock,et al.  What is the True Solubility Advantage for Amorphous Pharmaceuticals? , 2000, Pharmaceutical Research.

[2]  Thorsteinn Loftsson,et al.  Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  M. Lawrence,et al.  Ultrasonic degradation for molecular weight reduction of pharmaceutical cellulose ethers , 2011 .

[4]  Abu T M Serajuddin,et al.  Salt formation to improve drug solubility. , 2007, Advanced drug delivery reviews.

[5]  M. Carvajal,et al.  Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs , 1994 .

[6]  H. Bai,et al.  Thermal decomposition of cellulose ethers , 1999 .

[7]  Dave A. Miller,et al.  Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  Dave A. Miller,et al.  Dissolution Enhancement of a Drug Exhibiting Thermal and Acidic Decomposition Characteristics by Fusion Processing: A Comparative Study of Hot Melt Extrusion and KinetiSol® Dispersing , 2010, AAPS PharmSciTech.

[9]  Abu T M Serajuddin,et al.  Trends in solubility of polymorphs. , 2005, Journal of pharmaceutical sciences.

[10]  K. Nagapudi,et al.  Manufacture of pharmaceutical co-crystals using twin screw extrusion: a solvent-less and scalable process. , 2010, Journal of pharmaceutical sciences.

[11]  V. Stella,et al.  Prodrug strategies to overcome poor water solubility. , 2007, Advanced drug delivery reviews.

[12]  J Hadgraft,et al.  Crystallization of hydrocortisone acetate: influence of polymers. , 2001, International journal of pharmaceutics.

[13]  V. Soldi,et al.  Blends of hydroxypropyl methylcellulose and poly(1-vinylpyrrolidone-co-vinyl acetate) : Miscibility and thermal stability , 2005 .

[14]  Christopher J H Porter,et al.  Lipid-based systems for the enhanced delivery of poorly water soluble drugs. , 2008, Advanced drug delivery reviews.

[15]  J. van Humbeeck,et al.  Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[16]  C. M. Keary Characterization of METHOCEL cellulose ethers by aqueous SEC with multiple detectors , 2001 .

[17]  Elaine Merisko-Liversidge,et al.  Nanosizing: a formulation approach for poorly-water-soluble compounds. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[18]  James W McGinity,et al.  Fusion processing of itraconazole solid dispersions by kinetisol dispersing: a comparative study to hot melt extrusion. , 2010, Journal of pharmaceutical sciences.

[19]  J. Mcginity,et al.  Thermal processing of a poorly water-soluble drug substance exhibiting a high melting point: the utility of KinetiSol® Dispersing. , 2011, International journal of pharmaceutics.

[20]  W. Curatolo,et al.  Utility of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) for Initiation and Maintenance of Drug Supersaturation in the GI Milieu , 2009, Pharmaceutical Research.

[21]  L. D. Landro,et al.  Thermal and mechanical degradation during polymer extrusion processing , 2007 .

[22]  S. Yalkowsky,et al.  Estimation of the aqueous solubility I: application to organic nonelectrolytes. , 2001, Journal of pharmaceutical sciences.

[23]  David L Pole,et al.  Physical and biological considerations for the use of nonaqueous solvents in oral bioavailability enhancement. , 2008, Journal of pharmaceutical sciences.

[24]  C. Lipinski Poor aqueous solubility-an industry wide problem in drug discovery , 2002 .

[25]  P. Royall,et al.  The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems. , 1999, International journal of pharmaceutics.

[26]  Bruno C. Hancock,et al.  Amorphous Pharmaceutical Systems , 2013 .

[27]  Christian Leuner,et al.  Characterization of Solid Dispersions of Itraconazole and Hydroxypropylmethylcellulose Prepared by Melt Extrusion, Part II , 2003, Pharmaceutical Research.

[28]  C. Pouton,et al.  Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[29]  Wei Yang,et al.  Enhanced In Vivo Absorption of Itraconazole via Stabilization of Supersaturation Following Acidic-to-Neutral pH Transition , 2008 .

[30]  J Dressman,et al.  Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[31]  Lieven Baert,et al.  Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion--Part I. , 2003, International journal of pharmaceutics.

[32]  Patrick Augustijns,et al.  Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[33]  S. Riegelman,et al.  Pharmaceutical applications of solid dispersion systems. , 1971, Journal of pharmaceutical sciences.

[34]  Wei Yang,et al.  Targeted Intestinal Delivery of Supersaturated Itraconazole for Improved Oral Absorption , 2008, Pharmaceutical Research.

[35]  Allan S. Myerson,et al.  Polymorph Screening: Comparing a Semi-Automated Approach with a High Throughput Method , 2009 .

[36]  Richard J. Bastin,et al.  Salt Selection and Optimisation Procedures for Pharmaceutical New Chemical Entities , 2000 .

[37]  S. Yuk,et al.  Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. , 2004, International journal of pharmaceutics.

[38]  Dave A. Miller,et al.  Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[39]  S. Benita,et al.  Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[40]  Peddy Vishweshwar,et al.  Pharmaceutical co-crystals. , 2006, Journal of pharmaceutical sciences.

[41]  Patrick Augustijns,et al.  Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials. , 2007, Chemical communications.

[42]  Rainer H Müller,et al.  Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[43]  Neera Jain,et al.  Estimation of the aqueous solubility of weak electrolytes. , 2006, International journal of pharmaceutics.

[44]  Wei Yang,et al.  Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole. , 2008, Molecular pharmaceutics.

[45]  Dave A. Miller,et al.  Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol® Dispersing , 2010, Drug development and industrial pharmacy.

[46]  W. Mccrone,et al.  Pharmaceutical applications of polymorphism. , 1969, Journal of pharmaceutical sciences.

[47]  D. T. Friesen,et al.  Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. , 2008, Molecular pharmaceutics.

[48]  M. Brewster,et al.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. , 1996, Journal of pharmaceutical sciences.

[49]  Yatindra Joshi,et al.  Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system. , 2004, Journal of pharmaceutical sciences.

[50]  Bruno C. Hancock,et al.  Molecular Mobility of Amorphous Pharmaceutical Solids Below Their Glass Transition Temperatures , 1995, Pharmaceutical Research.